medalogix_logo-1.png

 

Medalogix Adds Five Members to its Tech Team

Nashville technology company employees medalogix.jpg

NASHVILLE, Tennessee, March 14, 2017 – Nashville-based healthcare predictive analytics firm, Medalogix, adds five new


New case study details how Medalogix’s predictive analytics technology helped major home health provider best deploy care to former patients, increase touchpoints with patients, manage end-of-life care 


Fierce_innovation_awards_16.pngNashville, TN – September 27, 2016 Medalogix announced today that is has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition 2016, an awards program from the publisher of FierceHealthcare, FierceHealthIT, and FierceHealthPayer



nbj_logo.jpgThe Nashville Business Journal published news of our new team members, Nick and Don. Learn more about them in the press release below. 


encompass_home_health_and_hospice_logo.png

Encompass Home Health & Hospice leverages Medalogix’s predictive analytics and automated calling solution to provide value-based care and reduce the risk of avoidable transfers by more than 50 percent



Beckers_Hospital_Review.pngWe couldn't be more thrilled! Becker's Hospital Review included us in their list: 30 Disruptive Healthcare Companies To Watch. See who else made the list in their article below:


logo5.jpg

Medalogix Announces Doctors’ Choice Home Health as Newest Client

The home health agency will use Medalogix’s analytics-based population health management tool, Touch, to help reduce hospital readmissions


medalogix_logo.png

Medalogix Releases End-of-Episode Planning Solution

Concluded beta-testing stage with select clients

Nashville, Tennessee, November 19, 2015 — Medalogix, a Nashville-based healthcare technology company, today announced the release of its new analytics-based end-of-episode (EOE) planning solution for home health agencies. The tool just concluded its beta-testing stage with two clients, Alternate Solutions Health Network and Great Lakes Caring Home Health.